SG49322A1 - Process - Google Patents

Process

Info

Publication number
SG49322A1
SG49322A1 SG1996009269A SG1996009269A SG49322A1 SG 49322 A1 SG49322 A1 SG 49322A1 SG 1996009269 A SG1996009269 A SG 1996009269A SG 1996009269 A SG1996009269 A SG 1996009269A SG 49322 A1 SG49322 A1 SG 49322A1
Authority
SG
Singapore
Application number
SG1996009269A
Other languages
English (en)
Inventor
Malcolm Carter
Martin Richard Owen
Philip Blatcher
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SG49322A1 publication Critical patent/SG49322A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996009269A 1993-09-29 1994-09-27 Process SG49322A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939320115A GB9320115D0 (en) 1993-09-29 1993-09-29 Process

Publications (1)

Publication Number Publication Date
SG49322A1 true SG49322A1 (en) 1998-05-18

Family

ID=10742727

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009269A SG49322A1 (en) 1993-09-29 1994-09-27 Process

Country Status (32)

Country Link
US (2) US5659040A (is)
EP (1) EP0721453B1 (is)
JP (1) JP3411284B2 (is)
CN (2) CN1132509A (is)
AP (1) AP529A (is)
AT (1) ATE228124T1 (is)
AU (1) AU682219B2 (is)
CA (1) CA2170645C (is)
CO (1) CO4290351A1 (is)
CZ (1) CZ287581B6 (is)
DE (1) DE69431759T2 (is)
DK (1) DK0721453T3 (is)
ES (1) ES2187534T3 (is)
FI (1) FI111162B (is)
GB (1) GB9320115D0 (is)
HK (1) HK1004218A1 (is)
HR (1) HRP940613B1 (is)
HU (1) HU226828B1 (is)
IL (1) IL111071A (is)
IS (1) IS1877B (is)
MY (1) MY117934A (is)
NO (1) NO309324B1 (is)
NZ (1) NZ274159A (is)
PE (1) PE18195A1 (is)
PL (1) PL178456B1 (is)
PT (1) PT721453E (is)
RU (1) RU2143428C1 (is)
SG (1) SG49322A1 (is)
SI (1) SI0721453T1 (is)
SK (1) SK282234B6 (is)
WO (1) WO1995009166A1 (is)
ZA (1) ZA947516B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69918799D1 (de) 1998-01-14 2004-08-26 Uab Res Foundation Birmingham Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO2006010078A2 (en) * 2004-07-08 2006-01-26 Dr. Reddy's Laboratories Ltd. Polymorphic form of naratriptan hydrochloride
WO2006010079A2 (en) * 2004-07-08 2006-01-26 Dr. Reddy's Laboratories Ltd. Process for preparing naratriptan hydrochloride
CN1315821C (zh) * 2004-12-16 2007-05-16 上海美通生物科技有限公司 制备n-甲基-3-(1-甲基-4-哌啶基)-1,4-吲哚-5-乙硫胺的改进法
AU2006306497A1 (en) * 2005-10-24 2007-05-03 Janssen Pharmaceutica, N.V. 3-piperidin-4-yl-indole ORL-1 receptor modulators
WO2009118753A2 (en) * 2008-03-07 2009-10-01 Usv Limited Process for preparation of naratriptan hydrochloride
CN101676283A (zh) * 2008-09-17 2010-03-24 北京德众万全药物技术开发有限公司 一种那拉曲坦的制备方法
CA2770178A1 (en) 2009-08-20 2011-02-24 Cipla Limited A process for the synthesis of naratriptan
CN101792411B (zh) * 2010-03-26 2012-05-30 常州晟永光电材料有限公司 一种合成乙磺酰胺的方法
CN103073484B (zh) * 2013-01-28 2014-10-22 山东诚创医药技术开发有限公司 一种甲哌卡因及其光学对映体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
IL87437A0 (en) * 1987-08-13 1989-01-31 Glaxo Group Ltd Indole derivatives,their preparation and pharmaceutical compositions containing them
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8903036D0 (en) * 1989-02-10 1989-03-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PE18195A1 (es) 1995-07-27
PL178456B1 (pl) 2000-05-31
JP3411284B2 (ja) 2003-05-26
FI961378A (fi) 1996-03-26
IS4212A (is) 1995-03-30
IS1877B (is) 2003-06-20
GB9320115D0 (en) 1993-11-17
AU682219B2 (en) 1997-09-25
ES2187534T3 (es) 2003-06-16
HK1004218A1 (en) 1998-11-20
CN1332166A (zh) 2002-01-23
WO1995009166A1 (en) 1995-04-06
DK0721453T3 (da) 2003-03-17
SK40696A3 (en) 1996-10-02
US5659040A (en) 1997-08-19
IL111071A0 (en) 1994-11-28
MY117934A (en) 2004-08-30
CZ287581B6 (en) 2000-12-13
HUT75642A (en) 1997-05-28
FI961378A0 (fi) 1996-03-26
AU7810194A (en) 1995-04-18
CZ76896A3 (en) 1996-06-12
CO4290351A1 (es) 1996-04-17
EP0721453A1 (en) 1996-07-17
EP0721453B1 (en) 2002-11-20
CA2170645C (en) 2005-11-15
ATE228124T1 (de) 2002-12-15
NO961252L (no) 1996-03-28
SK282234B6 (sk) 2001-12-03
US5786473A (en) 1998-07-28
AP529A (en) 1996-09-09
DE69431759T2 (de) 2003-07-03
AP9400676A0 (en) 1994-10-31
PT721453E (pt) 2003-03-31
HU226828B1 (en) 2009-11-30
NZ274159A (en) 1997-09-22
SI0721453T1 (en) 2003-04-30
RU2143428C1 (ru) 1999-12-27
NO309324B1 (no) 2001-01-15
IL111071A (en) 1998-10-30
DE69431759D1 (de) 2003-01-02
FI111162B (fi) 2003-06-13
CN1132509A (zh) 1996-10-02
HU9600814D0 (en) 1996-05-28
CA2170645A1 (en) 1995-04-06
NO961252D0 (no) 1996-03-28
JPH09502991A (ja) 1997-03-25
HRP940613A2 (en) 1997-06-30
ZA947516B (en) 1995-06-12
PL313740A1 (en) 1996-07-22
HRP940613B1 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
EP0701436A4 (en) PROCESS
GB9306409D0 (en) Process
GB9305902D0 (en) Process
GB9309458D0 (en) Process
GB9320115D0 (en) Process
GB9313723D0 (en) Process
GB9302331D0 (en) Process
GB9307245D0 (en) Process
GB9303770D0 (en) Process
GB9300309D0 (en) Process
GB9315081D0 (en) Process
GB9404778D0 (en) Process
GB9302302D0 (en) Process
GB9317464D0 (en) New process
GB9315477D0 (en) Process
GB9312594D0 (en) Process
GB9322068D0 (en) Process
GB9320645D0 (en) Process
GB9318920D0 (en) Process
GB9318809D0 (en) Process
GB9316252D0 (en) Process
GB9316163D0 (en) Process
GB9311952D0 (en) Process
GB9310874D0 (en) Process
GB9314344D0 (en) Process